Contact
Please use this form to send email to PR contact of this press release:
Arrowhead Research Corp.'s (ARWR) Hepatitis B Drug Placed on Partial Hold by FDA; CBCD Reviews a Report
TO:
Hanan Polansky
Lilac Corp.
5852509999